Accord Healthcare
Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
Falsified Medicines Directive
GROWTH’S IN OUR NATURE
Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK & Ireland.
Acquiring Actavis UK and Ireland in 2017 facilitates Accord’s ambition to become a top 5 pan-EMENA generics company by 2021 and have developed a specialty products commercialisation capability.
TRULY MULTINATIONAL
Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products to close to 65 EMENA markets.
A COMPLETE APPROACH
Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
EUROPEAN FOCUS
Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
News
Accord Healthcare in the News – BBC Feature 26 March 2020
Accord Healthcare featured on the BBC with Keith Daniels, Site Head for European Retail Production at Accord Healthcare’s site in Fawdon, Newcastle upon Tyne, discussing our continued...
Accord donates two million tablets of hydroxychloroquine to largest COVID-19 trial in the world involving 40,000 frontline healthcare workers
Today, 31 March 2020, Accord Healthcare Ltd, the principal European subsidiary of Intas Pharmaceuticals and the largest supplier by volume of generic medicines to the NHS, is collaborating on a...